|
1
|
Glassman AH: Cigarette smoking:
Implications for psychiatric illness. Am J Psychiatry. 150:546–553.
1993.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Balfour DJ and Fagerstrom KO: Pharmacology
of nicotine and its therapeutic use in smoking cessation and
neurodegenerative disorders. Pharmacol Ther. 72:51–81.
1996.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lichtensteiger W, Hefti F, Felix D,
Huwyler T, Melamed E and Schlumpf M: Stimulation of nigrostriatal
dopamine neurones by nicotine. Neuropharmacology. 21:963–968.
1982.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hukkanen J, Jacob P III and Benowitz NL:
Metabolism and disposition kinetics of nicotine. Pharmacol Rev.
57:79–115. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Henningfield JE and Zeller M: Nicotine
psychopharmacology: Policy and regulatory. Handb Exp Pharmacol.
511-534:2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Katner SN, Toalston JE, Smoker MP, Rodd
ZA, McBride WJ and Engleman EA: Time-course of extracellular
nicotine and cotinine levels in rat brain following administration
of nicotine: Effects of route and ethanol coadministration.
Psychopharmacology (Berl). 232:551–560. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Young W: Review of lithium effects on
brain and blood. Cell Transplant. 18:951–975. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kato S: Effects of platinum-coexisting
dopamine with X-ray irradiation upon human glioblastoma cell
proliferation. Hum Cell. 34:1653–1661. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bigner DD, Bigner SH, Ponten J, Westermark
B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF and Wikstrand CJ:
Heterogeneity of Genotypic and phenotypic characteristics of
fifteen permanent cell lines derived from human gliomas. J
Neuropathol Exp Neurol. 40:201–229. 1981.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shulepko MA, Bychkov ML, Lyukmanova EN and
Kirpichnikov MP: Recombinant analogue of the human protein SLURP-1
inhibits the growth of U251 MG and A172 glioma cells. Dokl Biochem
Biophys. 493:211–214. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ishiyama M, Tominaga H, Shiga M, Sasamoto
K, Ohkura Y and Ueno K: A combined assay of cell viability and in
vitro cytotoxicity with a highly water-soluble tetrazolium salt,
neutral red and crystal violet. Biol Pharm Bull. 19:1518–1520.
1996.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Milanovic D, Firat E, Grosu AL and
Niedermann G: Increased radiosensitivity and radiothermosensitivity
of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines
treated with the novel Hsp90 inhibitor NVP-HSP990. Radiat Oncol.
8(42)2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Baehner RL and Nathan DG: Leukocyte
oxidase: Defective activity in chronic granulomatous disease.
Science. 155:835–836. 1967.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Choi HS, Kim JW, Cha YN and Kim C: A
quantitative nitroblue tetrazolium assay for determining
intracellular superoxide anion production in phagocytic cells. J
Immunoassay Immunochem. 27:31–44. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Russell MA, Jarvis M, Iyer R and
Feyerabend C: Relation of nicotine yield of cigarettes to blood
nicotine concentrations in smokers. Br Med J. 280:972–976.
1980.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yasuda M, Ota T, Morikawa A, Mawatari K,
Fukuuchi T, Yamaoka N, Kaneko K and Nakagomi K: Simultaneous
determination of nicotine and cotinine in serum using
high-performance liquid chromatography with fluorometric detection
and postcolumn UV-photoirradiation system. J Chromatogr B Analyt
Technol Biomed Life Sci. 934:41–45. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bowman ER, Turnbull LB and Mc KH Jr:
Metabolism of nicotine in the human and excretion of pyridine
compounds by smokers. J Pharmacol Exp Ther. 127:92–95.
1959.PubMed/NCBI
|
|
18
|
Benowitz NL, Kuyt F, Jacob P III, Jones RT
and Osman AL: Cotinine disposition and effects. Clin Pharmacol
Ther. 34:604–611. 1983.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Riah O, Dousset JC, Courriere P, Stigliani
JL, Baziard-Mouysset G and Belahsen Y: Evidence that nicotine
acetylcholine receptors are not the main targets of cotinine
toxicity. Toxicol Lett. 109:21–29. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
de Sousa RT, Streck EL, Zanetti MV,
Ferreira GK, Diniz BS, Brunoni AR, Busatto GF, Gattaz WF and
Machado-Vieira R: Lithium increases leukocyte mitochondrial complex
I activity in bipolar disorder during depressive episodes.
Psychopharmacology (Berl). 232:245–250. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Karlin A: Structure of nicotinic
acetylcholine receptors. Curr Opin Neurobiol. 3:299–309.
1993.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lan YL, Wang X, Xing JS, Lou JC, Ma XC and
Zhang B: The potential roles of dopamine in malignant glioma. Acta
Neurol Belg. 117:613–621. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Egleton RD, Brown KC and Dasgupta P:
Nicotinic acetylcholine receptors in cancer: Multiple roles in
proliferation and inhibition of apoptosis. Trends Pharmacol Sci.
29:151–158. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ginzkey C, Stueber T, Friehs G, Koehler C,
Hackenberg S, Richter E, Hagen R and Kleinsasser NH: Analysis of
nicotine-induced DNA damage in cells of the human respiratory
tract. Toxicol Lett. 208:23–29. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Keiger CJ, Case LD, Kendal-Reed M, Jones
KR, Drake AF and Walker JC: Nicotinic cholinergic receptor
expression in the human nasal mucosa. Ann Otol Rhinol Laryngol.
112:77–84. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Papke RL, Sanberg PR and Shytle RD:
Analysis of mecamylamine stereoisomers on human nicotinic receptor
subtypes. J Pharmacol Exp Ther. 297:646–656. 2001.PubMed/NCBI
|
|
27
|
Hirata N, Yamada S, Asanagi M, Sekino Y
and Kanda Y: Nicotine induces mitochondrial fission through
mitofusin degradation in human multipotent embryonic carcinoma
cells. Biochem Biophys Res Commun. 470:300–305. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pastor N, Kaplan C, Dominguez I, Mateos S
and Cortes F: Cytotoxicity and mitotic alterations induced by
non-genotoxic lithium salts in CHO cells in vitro. Toxicol In
Vitro. 23:432–438. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bhagwat SV, Vijayasarathy C, Raza H,
Mullick J and Avadhani NG: Preferential effects of nicotine and
4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on
mitochondrial glutathione S-transferase A4-4 induction and
increased oxidative stress in the rat brain. Biochem Pharmacol.
56:831–839. 1998.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cormier A, Morin C, Zini R, Tillement JP
and Lagrue G: In vitro effects of nicotine on mitochondrial
respiration and superoxide anion generation. Brain Res. 900:72–79.
2001.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Miyazawa M, Kawauchi Y, Okuno Y and Oda Y:
The novel assay method for nicotine metabolism to cotinine using
high performance liquid chromatography. Chem Pharm Bull (Tokyo).
59:295–297. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rutledge SM and Asgharpour A: Smoking and
liver disease. Gastroenterol Hepatol (NY). 16:617–625.
2020.PubMed/NCBI
|
